financetom
Business
financetom
/
Business
/
Brazil's top court rules X must pay pending fines to resume service
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Brazil's top court rules X must pay pending fines to resume service
Oct 3, 2024 12:14 AM

SAO PAULO/BRASILIA (Reuters) -Brazilian Supreme Court said on Friday that social platform X needs to pay just over $5 million in pending fines in order to resume its service in the country, according to a court document.

Earlier this week, the Elon Musk-owned social platform told the court it had complied with orders to stop the spread of misinformation and asked it to lift a ban on the platform.

Judge Alexandre de Moraes responded with a ruling that X and its legal representative in Brazil must still agree to pay a total of 18.3 million reais ($3.4 million) in pending fines that were previously ordered by the court.

The judge also demanded a 10 million reais ($1.8 million) fine related to a brief period of time last week when X became available again for some users in Brazil.

X has been suspended since late August in Brazil, one of its largest and most coveted markets, after not complying with court orders related to restricting hate speech and failing to name a local legal representative, as required by Brazilian law.

($1 = 5.4341 reais)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
More Than $26M Bet On PBF Energy? Check Out These 3 Stocks Executives Are Buying
More Than $26M Bet On PBF Energy? Check Out These 3 Stocks Executives Are Buying
Sep 16, 2024
Although U.S. stocks closed higher on Friday, there were a few notable insider trades. When insiders purchase shares, it indicates their confidence in the company’s prospects or that they view the stock as a bargain. Either way, this signals an opportunity to go long on the stock. Insider purchases should not be taken as the only indicator for making an...
Exact Sciences' New Test Positively Identifies More than 88% of Cases of Colorectal Cancer, Company Says
Exact Sciences' New Test Positively Identifies More than 88% of Cases of Colorectal Cancer, Company Says
Sep 16, 2024
09:29 AM EDT, 09/16/2024 (MT Newswires) -- Exact Sciences ( EXAS ) was advancing in Monday's premarket activity, with shares rising over 4%, after the company presented performance data it said showed its blood-based screening test for colorectal cancer had an 88.3% sensitivity for the disease and 31.2% for advanced precancerous lesions. Both tests had a specificity of 90.1% for...
Metals-rich Kazakhstan seeks niche in battery supply chain
Metals-rich Kazakhstan seeks niche in battery supply chain
Sep 16, 2024
((This Sept. 13 has been corrected to fix the minister's surname throughout, to Sharlapaev from Sharlapayev)) By Olzhas Auyezov and Eric Onstad ALMATY (Reuters) - Kazakhstan aims to boost output of metals needed for electric vehicle (EV) batteries and is issuing hundreds of new exploration licences to attract fresh investment in the sector, the country's industry minister told Reuters. The...
NuCana Resistant Melanoma Treatment Data Shows Providing Some Relief After Disappointing Colorectal Cancer Data, Stock Surges
NuCana Resistant Melanoma Treatment Data Shows Providing Some Relief After Disappointing Colorectal Cancer Data, Stock Surges
Sep 16, 2024
On Saturday, NuCana plc ( NCNA )  presented final data from the Phase 2 NuTide:701 study at the ESMO Congress on NUC-7738 in combination with Merck & Co Inc's ( MRK ) Keytruda (pembrolizumab) for metastatic melanoma who were refractory to or had relapsed on prior PD-1 inhibitor therapy. In this 12-patient cohort, most patients had received at least two...
Copyright 2023-2026 - www.financetom.com All Rights Reserved